Page last updated: 2024-08-25

pentazirinocyclodiphosphathiazene and Bright Disease

pentazirinocyclodiphosphathiazene has been researched along with Bright Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carentz, F; Conte, JJ; Dueymes, M; Fournie, GJ; Labarre, JF; Mignon-Conte, M1

Other Studies

1 other study(ies) available for pentazirinocyclodiphosphathiazene and Bright Disease

ArticleYear
In vivo modulation of polyclonal activation of lymphocytes by SOAz, a cyclophosphazene derived drug. Prevention of murine glomerulonephritis induced by chronic injections of lipopolysaccharide.
    Clinical and experimental immunology, 1985, Volume: 59, Issue:1

    Topics: Animals; Antigen-Antibody Complex; Azirines; B-Lymphocytes; Dose-Response Relationship, Immunologic; Female; Glomerulonephritis; Immunoglobulins; Kidney; Lipopolysaccharides; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Time Factors

1985